Robert E. Pokusa

Robert E. Pokusa appears in our data through filings on Rock Creek Pharmaceuticals, Inc. shares, published by SEC (Form 4). The record holds 10 filings, for trades running from 29 August 2007 to 30 May 2012.

On the open market, the record shows 2 purchases worth €13k and 4 sales worth €528k. Sales outweigh purchases by €515k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant and 3 option exercises. In 2012 alone, the filings show no purchases and 2 sales.

The newest entry dates from 31 May 2012: an option exercise of €90k, in Rock Creek Pharmaceuticals, Inc. The last purchase on record was published on 12 November 2009, which is 6,205 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.